CM Free Writing Prospectus: Russell 2000 ARNs With 15.75-19.75% Cap
Rhea-AI Filing Summary
Canadian Imperial Bank of Commerce (CIBC) has filed a Free Writing Prospectus for Accelerated Return Notes (ARNs) linked to the Russell 2000 Index. Each unit is priced at $10 and carries a tenor of approximately 14 months. The notes provide a 300 % participation rate, delivering 3-to-1 upside on any positive index performance, but gains are capped at a Capped Value of $11.575-$11.975 per unit, equating to a maximum total return of 15.75 %-19.75 %.
Risk/return trade-off: Investors absorb 1-to-1 downside exposure on index losses and may lose up to 100 % of principal. The initial estimated value will be below the public offering price, secondary market liquidity may be limited, and the notes will not be exchange-listed. Payments depend on CIBC’s creditworthiness; a default would leave holders with no recovery. Investors also waive dividend rights and accept small-cap volatility inherent in the Russell 2000.
Target investor profile: The product suits investors who expect a moderate rise in the Russell 2000 over 14 months, are comfortable with a return cap, and can tolerate full principal risk and lack of interim income. It is not appropriate for those seeking capital preservation, dividend income, or uncapped equity exposure.
Key documentation: Full terms, tax considerations and risk factors are contained in the linked preliminary prospectus, product supplement and prospectus filed under SEC Registration No. 333-272447.
Positive
- 300 % participation rate offers leveraged upside for modest index gains.
- Short 14-month tenor reduces duration risk compared with longer-dated notes.
- Maximum return of up to 19.75 % may appeal to investors seeking defined payoff structures.
Negative
- Full 1-to-1 downside exposure can result in 100 % loss of principal.
- Return cap at $11.975 limits profit even if the Russell 2000 rallies strongly.
- Credit risk of CIBC; investor is an unsecured creditor in event of default.
- Initial estimated value is below offering price, creating negative carry at issuance.
- No exchange listing and potentially illiquid secondary market could lock investors in until maturity.
Insights
TL;DR: Routine structured note; high leverage but capped, full downside risk, minimal impact on CIBC fundamentals.
The ARNs provide an aggressive 300 % participation rate, attractive to tactical investors expecting single-digit index gains. However, the 15.75 %-19.75 % cap flattens returns beyond roughly 6 % index appreciation, limiting upside relative to direct equity exposure. Credit and liquidity risks remain typical for bank-issued structured notes: off-exchange trading, wide bid-ask spreads and an initial valuation discount. From CIBC’s perspective this is a standard capital-markets product with negligible balance-sheet impact. Therefore, the filing is operationally routine and not a catalyst for CM equity.
TL;DR: Niche product for bullish-but-cautious investors; risk/reward skew favours issuer, not portfolio core.
For allocation purposes, these ARNs substitute a covered-call-like payoff: limited gains, full losses. The payoff is justified only if an investor assigns high probability to Russell 2000 gains of 0-6 % within 14 months while discounting tail risk. Given recession concerns and small-cap volatility, the asymmetric profile looks unfavourable; equity or option overlays may achieve similar exposures with greater flexibility and liquidity. Consequently, I view the notes as a tactical satellite holding rather than a strategic allocation. Impact on broader markets is immaterial.
Filed Pursuant to Rule 433
Registration Statement No. 333-272447
| ACCELERATED RETURN NOTES® (ARNs®) | |
Accelerated Return Notes® Linked to the Russell 2000® Index
| Issuer | Canadian Imperial Bank of Commerce (“CIBC”) |
| Principal Amount | $10.00 per unit |
| Term | Approximately 14 months |
| Market Measure | The Russell 2000® Index (Bloomberg symbol: "RTY") |
| Payout Profile at Maturity |
· 3-to-1 upside exposure to increases in the Market Measure, subject to the Capped Value · 1-to-1 downside exposure to decreases in the Market Measure, with up to 100% of your investment at risk |
| Participation Rate | 300.00% |
| Capped Value | [$11.575 to $11.975] per unit, a [15.75% to 19.75%] return over the principal amount, to be determined on the pricing date. |
| Investment Considerations | This investment is designed for investors who anticipate that the Market Measure will increase moderately over the term of the notes, and are willing to accept a capped return, take full downside risk and forgo interim interest payments. |
| Preliminary Offering Documents | https://www.sec.gov/Archives/edgar/data/1045520/000110465925062822/tm2516701d29_fwp.htm |
| Exchange Listing | No |
You should read the relevant Preliminary Offering Documents before you invest. Click on the Preliminary Offering Documents hyperlink above or call your Financial Advisor for a hard copy.
Risk Factors
Please see the Preliminary Offering Documents for a description of certain risks related to this investment, including, but not limited to, the following:
| · | Depending on the performance of the Market Measure as measured shortly before the maturity date, you may lose up to 100% of the principal amount. |
| · | Your investment return is limited to the return represented by the Capped Value and may be less than a comparable investment directly in the stocks included in the Market Measure. |
| · | Payments on the notes, including any repayment of principal, are subject to the credit risk of CIBC, and actual or perceived changes in the creditworthiness of CIBC are expected to affect the value of the notes. If CIBC becomes insolvent or is unable to pay its obligations, you may lose your entire investment. |
| · | The initial estimated value of the notes on the pricing date will be less than their public offering price. |
| · | If you attempt to sell the notes prior to maturity, their market value may be lower than both the public offering price and the initial estimated value of the notes on the pricing date. |
| · | As a noteholder, you will have no rights of a holder of the securities represented by the Market Measure, and you will not be entitled to receive securities, dividends or other distributions by the issuers of those securities. |
| · | The notes are subject to risks associated with small-size capitalization companies. |
Final terms will be set on the pricing date within the given range for the specified Market-Linked Investment. Please see the Preliminary Offering Documents for complete product disclosure, including related risks and tax disclosure.
| The graph above and the table below reflect the hypothetical return on the notes, based on the terms contained in the table to the left (using the mid-point for any range(s)). The graph and the table have been prepared for purposes of illustration only and do not take into account any tax consequences from investing in the notes. |
| Hypothetical Percentage Change from the Starting Value to the Ending Value |
Hypothetical Redemption Amount per Unit |
Hypothetical Total Rate of Return on the Notes |
| -100.00% | $0.000 | -100.00% |
| -50.00% | $5.000 | -50.00% |
| -20.00% | $8.000 | -20.00% |
| -10.00% | $9.000 | -10.00% |
| -6.00% | $9.400 | -6.00% |
| -3.00% | $9.700 | -3.00% |
| 0.00% | $10.000 | 0.00% |
| 2.00% | $10.600 | 6.00% |
| 5.00% | $11.500 | 15.00% |
| 5.92% | $11.775(1) | 17.75% |
| 20.00% | $11.775 | 17.75% |
| 50.00% | $11.775 | 17.75% |
| 100.00% | $11.775 | 17.75% |
(1) The Redemption Amount per unit cannot exceed the hypothetical Capped Value.
Canadian Imperial Bank of Commerce (CIBC) has filed a registration statement (including a product supplement, a prospectus supplement, and a prospectus) with the U.S. Securities and Exchange Commission (SEC) for the offering to which this document relates. Before you invest, you should carefully read these documents and other documents that CIBC has filed with the SEC for more complete information about CIBC and this offering. You may get these documents without cost by visiting EDGAR on the SEC Website at www.sec.gov. CIBC's Central Index Key, or ClK, on the SEC website is 1045520. Alternatively, MLPF&S or BofAS will arrange to send you these documents if you so request by calling toll-free at 1-800-294-1322.
FAQ
What is the term of CIBC's Accelerated Return Notes (CM)?
How much upside do the CM ARNs provide?
Can investors lose principal on CIBC's Russell 2000 ARNs?
Are the CM ARNs exchange-listed?
What credit risk do investors face with these notes?
Where can I find the full prospectus for the CM Accelerated Return Notes?
